Equity Details
Price & Market Data
Price: $2.23
Daily Change: $0.00 / 0.00%
Daily Range: $2.14 - $2.25
Market Cap: $15,651,318
Daily Volume: 16,928
Performance Metrics
1 Week: 16.15%
1 Month: -4.29%
3 Months: -18.32%
6 Months: -53.54%
1 Year: -90.39%
YTD: -36.29%
About Vyome Holdings, Inc. (HIND)
Get the full picture of Vyome Holdings, Inc. (HIND). Price: 2.23, daily change: $0.00 / 0.00%. Market cap: 15,651,318. All performance metrics from 1-week to 1-year are here.
Company Details
Employees: 18
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechnology segments. The company's lead product candidate VT-1953, a dual DNA Gyrase/Topoisomerase inhibitor and immunomodulator in a topical gel formulation that is in phase 2 clinical stage for the treatment of bacterial conjunctivitis. It also develops VT-1908, a topical eye drop is an inosine 5'-monophosphate dehydrogenase enzyme inhibitor to treat immunoinflammatory conditions of the eye; and VB-1953, which is in phase 2 clinical stage for the treatment of inflammatory acne. In addition, the company develops antifungal products using the molecular replacement therapy (MRT) platform. It has a collaboration and license agreement with Sun Pharma Laboratories Limited to develop and commercialize next-generation antifungal products. The company is based in Cambridge, Massachusetts.
